Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction
- 1 October 2003
- journal article
- research article
- Published by Elsevier in American Journal Of Medicine
- Vol. 115 (6), 473-479
- https://doi.org/10.1016/s0002-9343(03)00435-2
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- ACE Inhibitors to Prevent End-Stage Renal DiseaseJournal of the American Society of Nephrology, 2001
- A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patientsJournal of the American College of Cardiology, 2001
- Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patientsThe Lancet, 2000
- Indications for ACE Inhibitors in the Early Treatment of Acute Myocardial InfarctionCirculation, 1998
- Early Versus Delayed Angiotensin-Converting Enzyme Inhibition Therapy in Acute Myocardial InfarctionCirculation, 1997
- Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery DiseaseCirculation, 1996
- ACE Inhibitor Use in Patients With Myocardial InfarctionCirculation, 1995
- Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart FailureJAMA, 1995
- Treatment of Mild Hypertension StudyJAMA, 1993
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985